Scandion Oncology Investor Relations Material
Scandion Oncology A/S is a clinical-stage biotechnology company, which focuses on developing medicines for the treatment of chemotherapy resistance. Scandion Oncology A/S was founded in 2017 and is headquartered in Copenhagen, Denmark.
Upcoming events for
Q3 20222022-11-16
Latest company events
More about Scandion Oncology
Ticker symbol
SCOL
Country
Sweden
About the company
Investor Relations Page
Dig deeper into the Scandion Oncology fundamentals on Quartr.
- Conference calls from all over the world
- Search for anything across all transcripts
- Consensus estimates
- Comprehensive financial data
- Read the transcripts or scroll the deck
- Slide decks and earnings reports
